Life sciences projects live at the intersection of innovation and regulation. From biopharmaceutical manufacturing and medical device production to emerging biotech and biomaterials, these facilities must meet exacting standards while moving at the speed demanded by competitive pipelines and finite patent windows. When the outcome affects patient health and product integrity, there’s little margin for error.
Whether you are developing a new greenfield facility, expanding an existing campus, or making targeted upgrades within an active operation, your building must be designed around process, equipment, and validation requirements from day one. Gray approaches life sciences construction by aligning facility systems with your operational realities so you can scale, validate, and manufacture with confidence.
The Life Sciences Industry Challenge
Life sciences companies operate in one of the most complex project environments in the world. Capital investments are significant; timelines are compressed, and regulatory scrutiny is constant. Life sciences facilities must be designed and constructed to meet current Good Manufacturing Practice (cGMP) requirements while supporting validation, inspection readiness, and long-term operational performance.
Delays in facility delivery can impact clinical timelines, manufacturing readiness, and revenue realization. Every decision, from site selection and utility infrastructure to ISO-classified cleanroom design, high-purity piping systems, and commissioning, must support long-term flexibility, cGMP compliance, and regulatory readiness. That level of coordination requires a clearly defined construction process aligned with scientific and operational realities—and, when needed, seamless integration of single-use technologies, bioreactors, fermenters, mixers, and other process-critical systems.
Through the Gray family of companies, customers gain access to turnkey solutions that extend beyond base building delivery. By aligning engineering, construction, equipment integration, and process coordination under one umbrella, Gray reduces handoffs, protects sensitive timelines, and ensures that facility infrastructure and production systems are designed to function as one cohesive environment.
The life sciences ecosystem extends far beyond traditional pharmaceuticals, encompassing a wide range of regulated, high-growth sectors that demand specialized facilities and disciplined execution. Gray is structured to support life sciences organizations across the full project lifecycle, aligning our integrated delivery model with the operational, regulatory, and scalability requirements unique to each market.
Our teams are equipped to deliver design and construction across a broad spectrum of life sciences sectors, including:
- Biopharmaceutical and pharmaceutical manufacturing
- Biotechnology and emerging biotech
- Medical device manufacturing
- Animal health and veterinary medicine
- Agriculture and food science innovation
- Nutraceuticals and food tech
- Biomaterials and bio fabrication
- Biofuels and industrial biotechnology
- Cold storage and life sciences distribution
Each segment carries distinct risk profiles, funding models, and regulatory expectations. Gray tailors project strategies to address those differences, whether you are advancing medical breakthroughs, scaling agricultural or food innovation, developing industrial biotechnology, or supporting environmental applications. Our teams align facility design, infrastructure, and critical process systems—including bioprocessing equipment and single-use technologies—so your building and production environment function as one integrated platform, helping you move from concept to commercialization with confidence.
Your Trusted Life Sciences Construction Company
Life sciences facilities are fundamentally different from conventional buildings. Your manufacturing process, equipment systems, validation protocols, and cGMP obligations drive the design from the start. Gray approaches every project with that complexity in mind, aligning planning, engineering, and construction around the operational realities that ultimately define your success — while respecting the confidentiality of your processes, data, and intellectual property.
In an industry where uncertainty and change are the norms, flexibility is not optional. Whether you are advancing a single product, scaling a pipeline, or adapting to evolving regulatory expectations, your facility must support multi-modal manufacturing, future process adjustments, and long-term growth. Gray’s integrated design-build approach encourages adaptable, scalable environments that protect your capital investment and safeguard sensitive operations while positioning you for what comes next.
By engaging early, managing procurement proactively, and sequencing work to support commissioning and validation, we help you bring facilities online faster without compromising compliance or performance. The result is a disciplined, flexible delivery model built for complexity and designed to evolve alongside your business.
Meet the Team
Gray has a deep bench of leaders with the experience to advise on your most complex challenges.
Related News & Insights
Frequently Asked Questions
Life sciences facilities are designed from the inside out, with manufacturing processes, equipment specifications, ISO-certified cleanroom classifications, and validation requirements dictating layout and infrastructure. Unlike conventional industrial facilities, where building systems often support standardized production, life sciences environments must integrate regulated manufacturing, controlled utilities, and rigorous documentation to meet strict compliance standards.
Speed to market is critical when your pipeline and patent timelines are on the line. An integrated design-build approach allows early alignment between design, engineering, procurement, and construction teams, reducing handoffs and minimizing rework. By sequencing construction to support commissioning and validation, facilities can move more efficiently from concept to operational readiness.
Yes. Life sciences projects often include specialized lab space for quality control, R&D, and process development alongside production areas. Whether you are building pilot-scale environments or full-production suites, the facility must support both experimentation and scalable operations within the same regulatory framework.
Uncertainty is inherent in this industry. Facilities must be flexible enough to support multi-modal production, future equipment upgrades, and evolving regulatory expectations. Designing adaptability ensures your investment continues to support advanced manufacturing without requiring complete redevelopment as products or processes shift.
A well-designed life sciences facility does more than meet immediate production needs—it positions companies to capitalize on FDA approval and limited patent exclusivity. By planning compliance, scalability, and future capacity from the outset, companies can launch faster, reduce regulatory risk, and maximize revenue during their most profitable window, all while protecting long-term capital investment.
You should look for a partner with experience coordinating process integration, clean utilities, high-purity piping, CQV collaboration, and compliance documentation in highly regulated environments. These projects must be designed around the manufacturing process itself. A partner with relevant experience understands how to coordinate all disciplines, anticipate regulatory expectations, and manage risk under collaborative delivery models like design-build. Experience in similar project types reduces risk and helps anticipate challenges before they impact the schedule or cost.
Facilities are the physical platforms that enable advanced research, regulated production, and commercial-scale-up across medical, agricultural, industrial, and environmental applications. When properly designed and delivered, they support safe, compliant environments where teams can develop life-saving innovations, advance food and bio-based technologies, and bring new products to market with confidence.
Life sciences construction projects require close coordination across architecture, engineering, construction, and process integration from the earliest planning stages. When these disciplines operate independently, misalignment can delay validation, increase cost, and introduce compliance risk—particularly around data integrity and 21 CFR Part 11 requirements.
An integrated delivery model aligns facility engineering, design, construction, clean utilities, high-purity piping systems, controls, structural systems, and IT/OT infrastructure around your manufacturing requirements. By engaging automation and controls teams early, electronic records, system architecture, and validation strategies can be designed intentionally rather than retrofitted late in the project. The result is greater cost certainty, accelerated schedules, and a smoother path through commissioning, qualification, and regulatory inspection, protecting both your capital investment and your capital investment and your speed-to-market.
Current Good Manufacturing Practice (cGMP) regulations govern how pharmaceutical, biopharmaceutical, and certain biotech products are manufactured. Your facility must be designed to support validated processes, controlled environments, proper material flows, and detailed documentation that demonstrate ongoing compliance. A construction partner experienced in cGMP environments understands how facility design decisions directly impact audit readiness, product integrity, and long-term operational success.
Call us at 859.281.5000 or send us a message using this contact form.